ArticleFrontiers in immunology2023

Efficacy and safety of rituximab for primary membranous nephropathy with different clinical presentations: a retrospective study.

Shasha Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.